pantethine has been researched along with chronic COVID syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Sater, F; Abou-Hamdan, M; Andreola, ML; Blondot, ML; De Reggi, M; Dournaud, P; Gressens, P; Laforge, M; Mani, S; Metifiot, M; Saleh, R | 1 |
1 other study(ies) available for pantethine and chronic COVID syndrome
| Article | Year |
|---|---|
Potential antiviral effects of pantethine against SARS-CoV-2.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; COVID-19; Humans; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Vero Cells; Virus Replication | 2023 |